Cargando…
Bioprocessing of Cryopreservation for Large-Scale Banking of Human Pluripotent Stem Cells
Human pluripotent stem cell (hPSC)-derived cell therapy requires production of therapeutic cells in large quantity, which starts from thawing the cryopreserved cells from a working cell bank or a master cell bank. An optimal cryopreservation and thaw process determines the efficiency of hPSC expansi...
Autores principales: | Li, Yan, Ma, Teng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559214/ https://www.ncbi.nlm.nih.gov/pubmed/23515461 http://dx.doi.org/10.1089/biores.2012.0224 |
Ejemplares similares
-
What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium?
por: Nakashima, Yoshiki, et al.
Publicado: (2016) -
Induced Pluripotent Stem Cells: Global Research Trends
por: Negoro, Takaharu, et al.
Publicado: (2017) -
Preconditioning Stem Cells for In Vivo Delivery
por: Sart, Sébastien, et al.
Publicado: (2014) -
Patent Application Trends of Induced Pluripotent Stem Cell Technologies in the United States, Japanese, and European Applications
por: Morita, Yasushi, et al.
Publicado: (2019) -
Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics
por: Sart, Sebastien, et al.
Publicado: (2021)